M. Sandström

H. Lundqvist, V. Tolmachev, M. Sandström, 2007, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases

M. Sandström, Ulrike Garske-Román, R. Nyman, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with (188)Re.

S. Ståhl, J. Löfblom, V. Tolmachev, 2014, European journal of medicinal chemistry.

Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule 111In-DOTA-ZIGF1R:4551

L. Abrahmsén, V. Tolmachev, A. Orlova, 2012, The Journal of Nuclear Medicine.

Kidney dosimetry during 177Lu-DOTATATE therapy in patients with neuroendocrine tumors: aspects on calculation and tolerance

N. Freedman, A. Sundin, M. Sandström, 2017, Acta oncologica.

Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

N. Freedman, A. Sundin, M. Sandström, 2020, EJNMMI Physics.

Evaluation of 99mTc-ZIGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression

V. Tolmachev, A. Orlova, Mohamed Altai, 2014, Amino Acids.

Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey

E. Spezi, C. Stokke, M. Sandström, 2017, EJNMMI Physics.

Influence of an aliphatic linker between DOTA and synthetic Z(HER2:342) Affibody molecule on targeting properties of the (111)In-labeled conjugate.

J. Feldwisch, V. Tolmachev, A. Orlova, 2011, Nuclear medicine and biology.

Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts

V. Tolmachev, A. Orlova, Mohamed Altai, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 affibody.

K. Wester, V. Tolmachev, A. Orlova, 2011, Nuclear medicine and biology.

Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE; Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine Neoplasms

Ezgi Ilan, M. Lubberink, A. Sundin, 2021, Cancers.

Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.

Vladimir Tolmachev, Hans Lundqvist, Mattias Sandström, 2007, Cancer research.

177Lu-DOTATATE Peptide Receptor Radionuclide Therapy: Dose Response in Small Intestinal Neuroendocrine Tumors

Ezgi Ilan, M. Lubberink, A. Sundin, 2019, Neuroendocrinology.

Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE

A. Sundin, M. Sandström, Ulrike Garske-Román, 2019, Cancers.

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

H. Lundqvist, A. Sundin, M. Sandström, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[177Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells

Vladimir Tolmachev, Mattias Sandström, Jörgen Carlsson, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry

S. Ståhl, V. Tolmachev, F. Frejd, 2009, Journal of Nuclear Medicine.

Regional lung perfusion estimated by electrical impedance tomography in a piglet model of lung collapse.

Gerardo Tusman, Göran Hedenstierna, Mattias Sandström, 2012, Journal of applied physiology.

Individualized dosimetry in patients undergoing therapy with 177Lu-DOTA-D-Phe1-Tyr3-octreotate

Anders Sundin, Hans Lundqvist, Mattias Sandström, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

In Vitro and In Vivo Evaluation of a 18F-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging

G. Antoni, G. Lindeberg, V. Tolmachev, 2013, PloS one.

Preclinical evaluation of anti-HER2 Affibody molecules site-specifically labeled with 111In using a maleimido derivative of NODAGA.

A. Karlström, V. Tolmachev, A. Orlova, 2012, Nuclear medicine and biology.

Disruption of HER2 signalling by the monoclonal antibody trastuzumab or the tyrosine kinase inhibitor lapatinib improves survival of patients with metastatic breast

Vladimir Tolmachev, Mattias Sandström, V. Tolmachev, 2010 .

Comparison of benzoate- and dodecaborate-based linkers for attachment of radioiodine to HER2-targeting Affibody ligand.

V. Tolmachev, A. Orlova, M. Sandström, 2007, International journal of molecular medicine.

Comparative Biodistribution and Radiation Dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in Patients with Neuroendocrine Tumors

Anders Sundin, Jens Sörensen, Mark Lubberink, 2013, The Journal of Nuclear Medicine.

Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels

Vladimir Tolmachev, Mattias Sandström, V. Tolmachev, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

HEHEHE-tagged affibody molecule may be purified by IMAC, is conveniently labeled with [⁹⁹(m)Tc(CO)₃](+), and shows improved biodistribution with reduced hepatic radioactivity accumulation.

L. Abrahmsén, S. Hosseinimehr, V. Tolmachev, 2010, Bioconjugate chemistry.

Optimal composition and position of histidine-containing tags improves biodistribution of 99mTc-labeled DARPin G3

A. Schulga, J. Löfblom, V. Tolmachev, 2019, Scientific Reports.

Phase I Study of 99mTc-ADAPT6, a Scaffold Protein–Based Probe for Visualization of HER2 Expression in Breast Cancer

S. Hober, V. Tolmachev, A. Orlova, 2020, The Journal of Nuclear Medicine.

Comparative evaluation of 111In-labeled NOTA‑conjugated affibody molecules for visualization of HER3 expression in malignant tumors.

S. Ståhl, J. Löfblom, V. Tolmachev, 2015, Oncology reports.

Evaluation of a maleimido derivative of NOTA for site-specific labeling of affibody molecules.

A. Karlström, V. Tolmachev, A. Orlova, 2011, Bioconjugate chemistry.

Parametric Net Influx Rate Images of 68Ga-DOTATOC and 68Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast

Anders Sundin, Mark Lubberink, Mattias Sandström, 2017, The Journal of Nuclear Medicine.

Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected tracer amount

Vladimir Tolmachev, Mattias Sandström, Anna Sjöberg, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force

Katarina Sjögreen Gleisner, Carlo Chiesa, Emiliano Spezi, 2017, EJNMMI Physics.

Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using 68Ga-DOTATOC and 68Ga-DOTATATE

Ezgi Ilan, M. Lubberink, A. Sundin, 2019, The Journal of Nuclear Medicine.

Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression

M. Lubberink, A. Sundin, M. Sandström, 2023, EJNMMI Research.

EANM enabling guide: how to improve the accessibility of clinical dosimetry

R. Hustinx, J. Tran-Gia, C. Stokke, 2023, European Journal of Nuclear Medicine and Molecular Imaging.

Method dependence, observer variability and kidney volumes in radiation dosimetry of 177Lu-DOTATATE therapy in patients with neuroendocrine tumours

Ezgi Ilan, N. Freedman, M. Sandström, 2015, EJNMMI Physics.

Noise correlation in PET, CT, SPECT and PET/CT data evaluated using autocorrelation function: a phantom study on data, reconstructed using FBP and OSEM

Ewert Bengtsson, Pasha Razifar, Harald Schneider, 2005, BMC Medical Imaging.

First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111In-ABY-025 Affibody Molecule

M. Lubberink, J. Carlsson, H. Lindman, 2014, The Journal of Nuclear Medicine.

Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule 111In-DOTA-ZIGF1R:4551

L. Abrahmsén, V. Tolmachev, A. Orlova, 2012, The Journal of Nuclear Medicine.

Regional lung perfusion estimated by electrical impedance tomography in a piglet model of lung collapse.

J. Borges, M. Amato, E. Costa, 2012, Journal of applied physiology.

ADAPT, a Novel Scaffold Protein-Based Probe for Radionuclide Imaging of Molecular Targets That Are Expressed in Disseminated Cancers.

S. Hober, J. Nilvebrant, Mikael Åstrand, 2015, Cancer research.